Page 13 - AN-1-1
P. 13

Advanced Neurology                                                          AIS in patients with COVID-19




                    Male, n   (%)  56 (69)  NA  178 (51)  24 (52.2)  731 (52.8)  20950   (51.3)  NA  NA  NA  9 (42.9)  366 (60.0)   -  -  24 (45.3)  -  -  -  (Contd...)


                 COVID-19 negative  Age, mean [SD]   or median [IQR]   (years)  70.1 (15.3)  NA  70 (15)  70 (18)  73 (61 – 82)  71 (60 – 81)   NA  NA  NA  73 (18)  72.4 (13.5)   -  -  65.9 (13.9)  -  -  -







                    Sample   Size  81  NA  355  46  1384  40 828  121  104  37  21  610  -  -  51  -  -  -



                    Male, n   (%)  12 (63)  108 (62.07)  31 (83)  23 (71.9)  47 (54.7)  615 (53.8)  NA  NA  NA  19 (79.2)  58 (63.7)   22 (57.9)  94 (60.6)  3 (33.3)  18 (58)  12 (60)  11 (65%)


                 COVID-19 positive  Age, mean   [SD] or median   [IQR] (years)  70.2 (8.4)  71.2 (12.3)  70 (15)  63 (17)  74.5 (67 – 84)  68 (57 – 79)  NA  NA  NA  59 (13)  71.6 (12.3)  74.5 (66.8 –   82.0)  -  58.2 (18.3)  69 (66 – 78)  64 (12)   75 (59 – 92)






                    Sample   size  19  174  37  32  86  1143  83  60  33  24  91  38  156  9    31  20   17




                 Study period  13 March – 15   May 20  27 January – 19   May 20  16 April 20 – 14   January 21  15 March – 19   April 20  9 March – 5 July 20  4 February – 29   June 20  1 March – 30 April   20  1 June – 31 Aug 20  13 March – 19   May 20  21 March – 12   April 20  Mid- March – 15   May 20  1 March – 1 Aug 20  1 March – 16 June   20  Late March – early   May 20  4 March – 2 May 20  15 March – 3 May   20  16 March – 9 April   20






                 Confirmation   of COVID-19  PCR  PCR, serology  RT-PCR  RT-PCR  RT-PCR  Not specified  PCR  RT-PCR  RT-PCR  RT-PCR  PCR  PCR  PCR, serology  PCR  PCR  RT-PCR  RT-PCR





                 Continent  Europe  Muliticenter  Asia,   Europe  North   America  Europe  North   America  North   America  Asia  North   America  North   America  Europe  Europe  North   America,   Europe,   Asia, Africa  North   America  North   America  North   America  Europe





                 Country  Spain  Muliticenter  Turkey  USA  UK  USA  USA  India  USA  USA  Spain  Netherlands  USA, Spain,   Egypt, Romania  USA  USA  USA  France






                 Design   cross-sectional  Prospective   cohort  Case-Control  Retrospective   cohort  case-control  Retrospective   cohort  Retrospective   cohort  Retrospective   cohort  Retrospective   cohort  Retrospective   cohort  Prospective   cohort  Prospective   cohort   Retrospective   cohort  cross-sectional  Retrospective   cohort  Retrospective   cohort  Retrospective   cohort
             Table 1. (Continued).  Year  Author  2021 Naval-Baudin   et al.  2020 Ntaios et al.  2021  Topcuoglu   et al.  2020  Yaghi et al.  2020  Perry et al.  2021  Srivastava   et al.  2021  Dhamoon   et al.  2020 Thomas et al.  2021  Ramos et al.  2020  Majidi et al.  2021  Martí-  Fàbregas   et al.  2021  Sluis et al.  2021  Ramos-  Araque et al.  2020  Lin et al.  2020 Merkler et al.  2020  Rothstein   et al.  2020 Kremer et al.











            Volume 1 Issue 1 (2022)                         5                        https://doi.org/10.36922/an.v1i1.28
   8   9   10   11   12   13   14   15   16   17   18